Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | CTNNB1 |
| Variant | T41A |
| Impact List | missense |
| Protein Effect | gain of function |
| Gene Variant Descriptions | CTNNB1 T41A lies within a Gsk3b phosphorylation site of the Ctnnb1 protein (UniProt.org). T41A confers a gain of function to the Ctnnb1 protein as demonstrated by nuclear accumulation of Ctnnb1 and increased Ctnnb1-dependent transcription (PMID: 10698519, PMID: 10487827, PMID: 12200448). |
| Associated Drug Resistance | |
| Category Variants Paths |
CTNNB1 mutant CTNNB1 act mut CTNNB1 T41A |
| Transcript | NM_001904.4 |
| gDNA | chr3:g.41224633A>G |
| cDNA | c.121A>G |
| Protein | p.T41A |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| XM_017005738.1 | chr3:g.41224633A>G | c.121A>G | p.T41A | RefSeq | GRCh38/hg38 |
| NM_001904.3 | chr3:g.41224633A>G | c.121A>G | p.T41A | RefSeq | GRCh38/hg38 |
| NM_001904.4 | chr3:g.41224633A>G | c.121A>G | p.T41A | RefSeq | GRCh38/hg38 |
| XM_024453356.2 | chr3:g.41224633A>G | c.121A>G | p.T41A | RefSeq | GRCh38/hg38 |
| XM_005264886 | chr3:g.41224633A>G | c.121A>G | p.T41A | RefSeq | GRCh38/hg38 |
| XM_006712985 | chr3:g.41224633A>G | c.121A>G | p.T41A | RefSeq | GRCh38/hg38 |
| XM_006712985.2 | chr3:g.41224633A>G | c.121A>G | p.T41A | RefSeq | GRCh38/hg38 |
| XM_047447479.1 | chr3:g.41224633A>G | c.121A>G | p.T41A | RefSeq | GRCh38/hg38 |
| NM_001098209 | chr3:g.41224633A>G | c.121A>G | p.T41A | RefSeq | GRCh38/hg38 |
| XM_047447477.1 | chr3:g.41224633A>G | c.121A>G | p.T41A | RefSeq | GRCh38/hg38 |
| XM_047447481.1 | chr3:g.41224633A>G | c.121A>G | p.T41A | RefSeq | GRCh38/hg38 |
| NM_001098210.2 | chr3:g.41224633A>G | c.121A>G | p.T41A | RefSeq | GRCh38/hg38 |
| XM_047447480.1 | chr3:g.41224633A>G | c.121A>G | p.T41A | RefSeq | GRCh38/hg38 |
| XM_024453356.1 | chr3:g.41224633A>G | c.121A>G | p.T41A | RefSeq | GRCh38/hg38 |
| XM_017005738 | chr3:g.41224633A>G | c.121A>G | p.T41A | RefSeq | GRCh38/hg38 |
| XM_047447483.1 | chr3:g.41224633A>G | c.121A>G | p.T41A | RefSeq | GRCh38/hg38 |
| XM_024453358.1 | chr3:g.41224633A>G | c.121A>G | p.T41A | RefSeq | GRCh38/hg38 |
| NM_001098209.1 | chr3:g.41224633A>G | c.121A>G | p.T41A | RefSeq | GRCh38/hg38 |
| XM_047447478.1 | chr3:g.41224633A>G | c.121A>G | p.T41A | RefSeq | GRCh38/hg38 |
| NM_001098209.2 | chr3:g.41224633A>G | c.121A>G | p.T41A | RefSeq | GRCh38/hg38 |
| XM_006712985.1 | chr3:g.41224633A>G | c.121A>G | p.T41A | RefSeq | GRCh38/hg38 |
| NM_001904 | chr3:g.41224633A>G | c.121A>G | p.T41A | RefSeq | GRCh38/hg38 |
| XM_017005738.2 | chr3:g.41224633A>G | c.121A>G | p.T41A | RefSeq | GRCh38/hg38 |
| NM_001098210.1 | chr3:g.41224633A>G | c.121A>G | p.T41A | RefSeq | GRCh38/hg38 |
| XM_024453357.1 | chr3:g.41224633A>G | c.121A>G | p.T41A | RefSeq | GRCh38/hg38 |
| NM_001098210 | chr3:g.41224633A>G | c.121A>G | p.T41A | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT04851119 | Phase Ib/II | Tegavivint | Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors | Recruiting | USA | 0 |